Milgrey Finance & Investments has approved the acquisition of a 60% equity stake in Fidus Parkland Pvt Ltd for a consideration of ₹49.80 crore. The transaction, executed through a share swap arrangement, marks the company’s entry into the real estate sector.

The Board of Directors approved the proposal during its meeting held on August 21, 2026. The acquisition is based on a current valuation of ₹83 crore for the target entity. The share swap ratio will be determined by the Board in due course, guided by independent valuation reports and fairness opinions.

Transaction Details

Fidus Parkland Pvt Ltd is engaged in the real estate business. Milgrey aims to diversify its business activities through this strategic move. The company stated that no governmental or regulatory approvals are required for the acquisition.

The transaction is not classified as a related-party transaction, and the promoter group has no interest in the target entity. The deal is structured at arm's length.

What the Numbers Show

The acquisition cost of ₹49.80 crore represents approximately 60% of the target’s stated valuation of ₹83 crore, aligning directly with the equity stake being acquired. This indicates a straightforward valuation-based pricing mechanism without significant premium or discount adjustments disclosed in the filing.

Milgrey Finance & Investments has adjourned its Board Meeting scheduled for Tuesday, August 11, 2026, to Thursday, August 13, 2026. The company disclosed the change in schedule via an intimation to the Bombay Stock Exchange (BSE) on August 11, 2026, citing a decision made by the Chairman with the consent of all directors present at the earlier gathering. Investors awaiting the quarterly performance update must now look to the new date for the approval of the first quarter’s un-audited financial results.

The procedural shift was formalized under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The original intimation, issued on August 6, 2026, had set August 11 as the date for the Board of Directors and Audit Committee to convene. The primary agenda remains unchanged: the consideration and approval of the un-audited financial results for the quarter ended June 30, 2026.

Key Dates and Agenda

The following table outlines the revised timeline for the corporate action:

The meeting will also address any other items with the permission of the Chairman, as permitted under the regulations. The decision to adjourn was taken during the initial gathering on August 11, ensuring that all present directors were in agreement with the postponement.

Regulatory Compliance

The company’s communication to the BSE included its scrip code, ZMILGFIN (511018), and referenced the specific regulatory framework governing such disclosures. The intimation was signed by Abhay Narain Gupta, Director, confirming the validity of the procedural adjustment. No specific reason for the adjournment, such as technical issues or absence of key members, was provided in the disclosure, only the consensus of the directors present.

What This Means for Shareholders

Shareholders should note that the release of the Q1FY27 financial results is now delayed by two days. The results will be approved on August 13, 2026, rather than August 11. There is no indication of a delay in the subsequent filing of these results with the stock exchanges, which typically follows shortly after board approval. Investors monitoring the company’s performance for the quarter ended June 30, 2026, should adjust their calendars accordingly.